Journal article icon

Journal article

Sickle cell disease: the price of cure

Abstract:
In this issue of Blood, the first prospective trial of unrelated donor bone marrow transplantation (BMT) in children with sickle cell disease (SCD), reported by Shenoy et al, is an important step in extending curative therapy to more children with severe disease.
Publication status:
Published
Peer review status:
Reviewed (other)
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1182/blood-2016-10-740969

Authors


More by this author
Department:
Oxford, MSD, Paediatrics
de la Fuente, J More by this author
Publisher:
American Society of Hematology Publisher's website
Journal:
Blood Journal website
Volume:
128
Issue:
21
Pages:
2486-2488
Publication date:
2016-11-24
DOI:
EISSN:
1528-0020
ISSN:
0006-4971
Pubs id:
pubs:664025
URN:
uri:2b9636da-8d44-4558-91c0-91eb16c07dbb
UUID:
uuid:2b9636da-8d44-4558-91c0-91eb16c07dbb
Local pid:
pubs:664025
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP